Loading...
Advances in non-dopaminergic treatments for Parkinson's disease
Since the 1960's treatments for Parkinson's disease (PD) have traditionally been directed to restore or replace dopamine, with L-Dopa being the gold standard. However, chronic L-Dopa use is associated with debilitating dyskinesias, limiting its effectiveness. This has resulted in extensive...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Frontiers Media S.A.
2014
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4033125/ https://ncbi.nlm.nih.gov/pubmed/24904259 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnins.2014.00113 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|